MRI联合靶向活检对前列腺癌主动监测终止率的影响:PRIAS研究反思
基于PRIAS前瞻性研究三个GG1亚组,评估MRI与靶向活检对主动监测终止率的影响。诊断前MRI组2年终止率24.2%,GG再分级占13.4%;诊断后6月内MRI组终止率30.9%,GG再分级占22.8%;无MRI组终止率27.5%,GG再分级占6.9%。提示诊断前MRI可降低终止率,而监测中MRI增加因GG再分级导致的终止。
要点
- 诊断前MRI可降低2年主动监测终止率(24.2% vs 27.5%)
- 监测中MRI增加终止率(30.9%)且GG再分级占比升至22.8%
- MRI提高诊断准确性可能致过度治疗,需调整显著癌定义
核心结论
- 诊断前MRI降低2年主动监测终止累积概率,监测中MRI增加终止概率尤其因GG再分级。
- MRI使用可能导致更多患者被认为不适合主动监测,若显著癌定义不调整或致过度治疗。
研究设计与样本
- PRIAS前瞻性研究三个GG1亚组:A组(n=500)2009年前诊断无MRI;B组(n=351)诊断无MRI但6月内行MRI;C组(n=435)诊断前及随访中行MRI。
- 采用累积 incidence 曲线估计终止率,三组非随机但基线特征高度可比。
主要发现
- A组2年终止累积概率27.5%,GG再分级占6.9%。
- B组2年终止累积概率30.9%,GG再分级占22.8%。
- C组2年终止累积概率24.2%,GG再分级占13.4%。
临床怎么用
- 启动主动监测前考虑行MRI以降低终止率。
- 监测中MRI发现GG再分级增加终止,需权衡过度治疗风险。
局限性
- 三组非随机化,虽基线特征高度可比但可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The reduction of overtreatment by active surveillance (AS) is limited in patients with low-risk prostate cancer (PCa) due to high rates of patients switching to radical treatment. MRI improves biopsy accuracy and could therewith affect inclusion in or continuation of AS. We aim to assess the effect of MRI with target biopsies on the total rate of patients discontinuing AS, and in particular discontinuation due to Grade Group (GG) reclassification. METHODS: Three subpopulations included in the prospective PRIAS study with GG 1 were studied. Group A consists of patients diagnosed before 2009 without MRI before or during AS. Group B consists of patients diagnosed without MRI, but all patients underwent MRI within 6 months after diagnosis. Group C consists of patients who underwent MRI before diagnosis and during follow-up. We used cumulative incidence curves to estimate the rates of discontinuation. RESULTS: In Group A (n = 500), the cumulative probability of discontinuing AS at 2 years is 27.5%; GG reclassification solely accounted for 6.9% of the discontinuation. In Group B (n = 351) these numbers are 30.9 and 22.8%, and for Group C (n = 435) 24.2 and 13.4%. The three groups were not randomized, however, baseline characteristics are highly comparable. CONCLUSIONS: Performing an MRI before starting AS reduces the cumulative probability of discontinuing AS at 2 years. Performing an MRI after already being on AS increases the cumulative probability of discontinuing AS in comparison to not performing an MRI, especially because of an increase in GG reclassification. These results suggest that the use of MRI could lead to more patients being considered unsuitable for AS. Considering the excellent long-term cancer-specific survival of AS before the MRI era, the increased diagnostic accuracy of MRI could potentially lead to more overtreatment if definitions and treatment options of significant PCa are not adapted.
引用
- Luiting HB, Remmers S, Valdagni R, et al. What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study. Prostate Cancer Prostatic Dis. 2021. PMID: 33833378. doi:10.1038/s41391-021-00343-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。